Noble Roman's, Inc.
NROM · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $4,080 | $3,760 | $3,699 | $3,880 |
| % Growth | 8.5% | 1.7% | -4.7% | – |
| Cost of Goods Sold | $2,678 | $2,730 | $2,485 | $2,791 |
| Gross Profit | $1,402 | $1,030 | $1,213 | $1,089 |
| % Margin | 34.4% | 27.4% | 32.8% | 28.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $386 | $424 | $928 | $566 |
| SG&A Expenses | $386 | $424 | $928 | $566 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $102 | $104 | $217 | $106 |
| Operating Expenses | $488 | $528 | $1,145 | $672 |
| Operating Income | $914 | $502 | $68 | $417 |
| % Margin | 22.4% | 13.3% | 1.8% | 10.7% |
| Other Income/Exp. Net | -$424 | -$330 | -$393 | -$223 |
| Pre-Tax Income | $490 | $172 | -$324 | $193 |
| Tax Expense | $120 | $41 | -$157 | $0 |
| Net Income | $371 | $131 | -$167 | $193 |
| % Margin | 9.1% | 3.5% | -4.5% | 5% |
| EPS | 0.017 | 0.006 | -0.009 | 0.009 |
| % Growth | 183.1% | 162.8% | -208% | – |
| EPS Diluted | 0.015 | 0.005 | -0.009 | 0.008 |
| Weighted Avg Shares Out | 22,216 | 22,216 | 22,216 | 22,216 |
| Weighted Avg Shares Out Dil | 25,008 | 25,279 | 22,216 | 24,150 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $424 | $330 | $393 | $416 |
| Depreciation & Amortization | $133 | $190 | $211 | $96 |
| EBITDA | $1,047 | $692 | $279 | $705 |
| % Margin | 25.7% | 18.4% | 7.6% | 18.2% |